Article Information
History
- January 11, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1COMPutational pharmacology and clinical Oncology Department, Inria Sophia Antipolis – Méditerranée, Cancer Research Center of Marseille, Inserm UMR1068, CNRS UMR7258, Aix Marseille University UM105, Marseille, France
- 2Center of Mathematics, Technical University of Munich, Garching (Munich), Germany
- 3Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique - Hôpitaux de Marseille, Aix Marseille University, Marseille, France
- 4Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France
- ↵†Corresponding author: sebastien.benzekry{at}inria.fr, Faculté de Pharmacie, 27 boulevard Jean Moulin, 13005 Marseille, France, +33695725707
↵* These authors contributed equally and are co-first authors in alphabetical order.